​

Iterum Therapeutics (ITRM) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Iterum Therapeutics Revenue Highlights

0

Latest Revenue (Q)

$390.00K

Iterum Therapeutics Revenue by Period

Iterum Therapeutics Revenue by Year

DateRevenueChange
2024-12-31-100.00%
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31--100.00%
2019-12-31$37.00K-95.74%
2018-12-31$869.00K71.06%
2017-12-31$508.00K100.00%
2016-12-31--

Iterum Therapeutics generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Iterum Therapeutics Revenue by Quarter

DateRevenueChange
2025-09-30$390.00K100.00%
2025-06-30-100.00%
2025-03-31-100.00%
2024-12-31-100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$2.62M100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30--100.00%
2019-03-31$37.00K-84.52%
2018-12-31$239.00K-5.91%
2018-09-30$254.00K37.30%
2018-06-30$185.00K-3.14%
2018-03-31$191.00K-45.27%
2017-12-31$349.00K119.50%
2017-09-30$159.00K100.00%
2017-06-30-100.00%
2017-03-31--

Iterum Therapeutics generated $390.00K in revenue during Q3 2025, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Iterum Therapeutics Revenue Breakdown

Iterum Therapeutics Revenue Breakdown by Product

Quarterly Revenue by Product

Product/ServiceSep 25
Operating Segments$390.00K

Iterum Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Sep 25: Operating Segments (100.00%).

Iterum Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
PLURPluri$1.34M$427.00K
QTTBQ32 Bio$1.16M-
RLYBRallybio$636.00K$212.00K
IBIOiBio$400.00K$100.00K
SONNSonnet BioTherapeutics$147.81K-
KLTOKlotho Neurosciences--
ANTXAN2 Therapeutics--
ITRMIterum Therapeutics-$390.00K
BOLDBoundless Bio--
INTSIntensity Therapeutics--
TAOXTAO Synergies--

ITRM Revenue FAQ

What is Iterum Therapeutics’s yearly revenue?

Iterum Therapeutics's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. ITRM's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is Iterum Therapeutics’s quarterly revenue?

Iterum Therapeutics's quarterly revenue for Q3 2025 was $390K, a 100.00% increase from the previous quarter (Q2 2025), and a 0% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $0, a 100.00% increase from the previous quarter (Q1 2025), and a 0% increase year-over-year (Q2 2024). ITRM's quarterly revenue for Q1 2025 was $0, a 100.00% increase from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024).

What is Iterum Therapeutics’s revenue growth rate?

Iterum Therapeutics's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 0%.